Steward Partners Investment Advisory’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Steward Partners Investment Advisory’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-233	Closed	-$30.7K	–	4277
2025 Q1	$30.7K	Sell	233 -8	-3%	-$997	﹤0.01%	2618
2024 Q4	$20.1K	Buy	+241	New	+$19.8K	﹤0.01%	2793

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Steward Partners Investment Advisory's ITCI Position: Q2 2025 in Review

Steward Partners Investment Advisory sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 233 shares — an estimated $30.7K sold.

Steward Partners Investment Advisory first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $30.7K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Steward Partners Investment Advisory reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Steward Partners Investment Advisory sold 233 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $30.7K.
Steward Partners Investment Advisory first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
Steward Partners Investment Advisory's Intra-Cellular Therapies Inc. position peaked at $30.7K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.